Biotech success, 2002 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech success, 2002

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (5)	1/18/2002 8:39:07 PM
From: Amots	of 117

scott. "Preclinical studies have shown that TA-1790 is equally as effective as sildenafil, the active ingredient in Viagra, in inducing penile rigidity in several different animal species, including primates. In vitro studies have demonstrated that TA-1790 inhibits PDE5 more selectively than does sildenafil. In these studies, sildenafil demonstrated greater inhibition of other PDE enzymes, which may result in unwanted side effects in tissues and organs. TA-1790 has also been shown in in vitro models to cause less inhibition at adenosine receptors; adenosine may play a role in maintaining normal cardiac rhythm. " pharmalicensing.com And: vivus.com BR Amots

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next